Price target in 14 days: 40.791 USD. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. The company ...Drugmaker Pfizer Inc is in concurrent talks with the European Union as well as several of its member states to sell them the ...Pfizer Inc. (NYSE: PFE) reported forecast-beating second-quarter results Tuesday and raised its full-year guidance. Earnings however declined 2% year over year due to lower revenues and ...Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Pfizer ...On its last earning announcement, the company reported a profit of 2.80$ per share.Pfizer Inc <PFE.N> beat analysts' estimates for second-quarter profit on Tuesday and raised its full-year forecast, as demand ...At the moment the company generates 50660M USD in revenues.Any opinions, news, research, analyses, prices, or other information offered by AIStockFinder is provided as general market commentary, and does not constitute investment advice. Pfizer employs 88,300 workers across the globe.Please log in to your account or sign up in order to add this asset to your watchlist.Pfizer updated its FY20 earnings guidance on Tuesday, July, 28th. The companies that make these products are buy-and-hold gems. PEG Ratios above 1 indicate that a company could be overvalued.Receive a free world-class investing education from MarketBeat. In the short term (2weeks), PFE's stock price should outperform the market by 0.17%.During that period the price should oscillate between -2.38% and +2.36%.. Factset: FactSet Research Systems Inc.2019. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Pfizer announced that its board has authorized a share buyback plan on Friday, December 14th 2018, which authorizes the company to repurchase $10,000,000,000.00 in shares, according to EventVestor. This indicates that Pfizer will be able to sustain or increase its dividend.One share of PFE stock can currently be purchased for approximately $39.26.Only 0.08% of the stock of Pfizer is held by insiders.70.20% of the stock of Pfizer is held by institutions. In the medium term (3months), PFE's stock price should outperform the market by 1.27%. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. Exploring Pfizer (NYSE:PFE) stock? Get short term trading ideas from the MarketBeat Idea Engine. View PFE's stock price, price target, dividend, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. In turbulent times like these, stick with companies that make the essentials — that means companies like Pfizer. As of 2020 July 20, Monday current price of 500680 stock is 4129.650$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). PFE | Complete Pfizer Inc. stock news by MarketWatch. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Pharmaceuticals fall into this category. This payout ratio is at a healthy, sustainable level, below 75%.Sign-up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter.Pfizer has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Pfizer has a P/B Ratio of 3.43. In the last reported quarter, the company delivered a positive earnings surprise of 12.68%. The company's average rating score is 2.33, and is based on 4 buy ratings, 8 hold ratings, and no sell ratings.The dividend payout ratio of Pfizer is 51.53%. Sales dropped 11% to $11.80 billion from $13.26 billion year-on-year, exceeding analyst consensus of $11.58 billion.The stock rose almost 4% to $39.02 at the close on Tuesday as Pfizer raised its annual sales range guidance to $40.8 billion to $42.4 billion. The stock rose almost 4% to $39.02 at the close on Tuesday as Pfizer raised its annual sales range guidance to $40.8 billion to $42.4 billion. "Shares of PFE can be purchased through any online brokerage account. Investors can use this forecasting interface to forecast Pfizer historical stock prices and determine the direction of Pfizer Inc's future trends based on various well-known forecasting models. All times are ET.